June 5, 2008 — A case study concerning the Axiom Worldwide’s DRX9000, published in the 2008 issue of the European Musculoskeletal Review, was mentioned in an online newsletter from the Food and Drug Administration (FDA).
The FDA news item was headlined, “Axiom Case Study Yields Favorable Findings with Back Pain Device.”
It read, in part, “A study evaluating Axiom Worldwide’s DRX9000 true nonsurgical spinal decompression system has produced positive results. … The study chronicled a patient who underwent 22 treatments with the device over a seven-week period and reported significant pain relief at the end of the study.”
Source: Axiom WorldWide, www.axiomworldwide.com
Related Posts
Canadian chiropractors, colleges battle over X-rays- Clearing up confusion about hemp supplements
- The viral link between COVID, gut health and immunity
- ICA and chiropractic community mourn the passing of chiropractic warrior and international leader James Sigafoose
- Dear graduate …
- A phase angle formula for improving cell membrane health – Part III
